7.2 Vascular Ulcers (Venous vs. Arterial) & Diabetic Foot Ulcers

7.2 Vascular Ulcers (Venous vs. Arterial) & Diabetic Foot Ulcers

Quick Summary: Chronic lower extremity ulcerations constitute a major proportion of homebound community paramedicine referrals. Clinicians must rapidly differentiate between venous stasis, arterial ischemic, and neuropathic diabetic etiologies. Initiating compression therapy on an unrecognized ischemic limb can precipitate acute limb loss, while failing to identify Charcot foot or a positive probe-to-bone sign in a diabetic ulcer leads to catastrophic osteomyelitis and amputation. Domain 3 requires mastery of vascular physical diagnostics, Ankle-Brachial Index (ABI) metrics, monofilament sensory testing, and offloading principles.

Lower extremity ulcers affect millions of older adults, with chronic venous insufficiency accounting for approximately $70%$ of cases, arterial insufficiency accounting for $10\text{ to }15%$, and diabetic neuropathy accounting for $15\text{ to }20%$. Because these pathophysiological mechanisms diverge completely, treatment strategies are often mutually exclusive. For instance, high-level sustained compression therapy is the absolute gold-standard cure for venous hypertension, yet applying that same compression bandage to a patient with severe peripheral arterial disease will rapidly cause arterial thrombosis, ischemic gangrene, and limb amputation.

---

Venous Stasis Ulcers (Venous Hypertension)

Pathophysiology

Venous ulcers develop secondary to chronic venous insufficiency (CVI) and persistent ambulatory venous hypertension. Under normal conditions, the deep calf-muscle pump contracture during ambulation propels venous blood cephalad against gravity toward the inferior vena cava, while competent one-way bicuspid venous valves prevent retrograde reflux. When these valves become incompetent (due to deep vein thrombosis, phlebitis, congenital weakness, or chronic venous dilation), blood flows retrograde into the superficial venous network.

┌────────────────────────────────────────────────────────────────────────┐
│               PATHOGENESIS OF VENOUS STASIS ULCERATION                 │
├────────────────────────────────────────────────────────────────────────┤
│ Valvular Incompetence + Calf-Pump Failure                              │
│                             │                                          │
│                             ▼                                          │
│ Persistent Ambulatory Venous Hypertension                              │
│                             │                                          │
│                             ▼                                          │
│ Microvascular Capillary Distension & Endothelial Pore Widening         │
│                             │                                          │
│                             ▼                                          │
│ Extravasation of Macromolecules (Fibrinogen) & Red Blood Cells (RBCs)  │
│                             │                                          │
│              ┌──────────────┴──────────────┐                           │
│              ▼                             ▼                           │
│ RBC Lysis & Hemosiderin Deposition   Pericapillary "Fibrin Cuffs"      │
│ (Hyperpigmentation & Dermatitis)     (Barrier to Oxygen Diffusion)     │
│              │                             │                           │
│              └──────────────┬──────────────┘                           │
│                             ▼                                          │
│ Leukocyte Trapping, Protease Release, Lipodermatosclerosis & Ulceration│
└────────────────────────────────────────────────────────────────────────┘

This chronic ambulatory hypertension increases hydrostatic pressure within the dermal capillary bed, widening endothelial intercellular junctions. High-molecular-weight proteins, particularly fibrinogen, leak into the interstitial space and polymerize into dense pericapillary "fibrin cuffs." Simultaneously, red blood cells extravasate into the dermis and lyse, breaking down into iron-rich hemosiderin pigments. Trapped white blood cells release inflammatory cytokines, tumor necrosis factor-alpha (TNF-$\alpha$), and matrix metalloproteinases (MMPs). This chronic inflammatory environment culminates in dermal fibrosis, subcutaneous fat necrosis (lipodermatosclerosis), epidermal atrophy, and spontaneous ulceration triggered by minimal micro-trauma.

Clinical Presentation & Hallmarks

• Anatomical Distribution: Located characteristically within the "gaiter zone" (the lower third of the lower leg extending from the mid-calf down to the malleoli), with a marked predilection for the medial malleolus.
• Wound Appearance: Irregular, ragged, gently sloping wound edges. The wound bed is typically shallow, beefy red, and highly vascularized with granulation tissue, or covered by moist, yellow fibrous slough.
• Exudate: Moderate to heavy / copious serous or serosanguinous exudate that frequently saturates dressings and macerates surrounding skin.
• Surrounding Cutaneous Changes:
  • Hemosiderin Staining: Distinctive brown, rust-colored, or bronze hyperpigmentation of the lower leg.
  • Stasis Dermatitis: Erythematous, scaling, pruritic, weeping eczematous changes.
  • Lipodermatosclerosis: Chronic subcutaneous induration and circumferential fibrotic contraction of the lower leg, yielding an "inverted champagne bottle" or "bowling pin" appearance.
  • Atrophie Blanche: Smooth, ivory-white, sclerotic stellate plaques reflecting avascular dermal scar tissue studded with tortuous dilated capillary loops.
• Pain Pattern: Described as a dull, heavy, throbbing ache that worsens with prolonged standing or dependency and is significantly relieved by leg elevation above heart level.

Compression Therapy: Principles & Boundaries

Compression therapy is the cornerstone of venous ulcer healing. By counteracting hydrostatic gravity pressure, compression decreases deep and superficial venous diameter, restores valvular competence, accelerates deep venous velocity, reduces interstitial edema, and enhances lymphatic drainage.

• Therapeutic Pressure: Standard therapeutic venous compression delivers $30\text{ to }40\text{ mmHg}$ of graduated sub-bandage pressure at the ankle, tapering to approximately $70%$ ($20\text{ to }28\text{ mmHg}$) at the calf (e.g., multilayer elastic wrap systems, unna boots, or short-stretch cohesive bandages).
• Prerequisite Assessment: A reliable Ankle-Brachial Index (ABI) is mandatory prior to applying sustained therapeutic compression.
• Absolute Contraindications to Compression Therapy:
  1. Severe Peripheral Arterial Disease: $\text{ABI} < 0.5$ or absolute ankle systolic pressure $< 50\text{--}60\text{ mmHg}$.
  2. Acute Decompensated Congestive Heart Failure: External compression mobilizes large volumes of peripheral fluid into the central circulation, precipitating acute pulmonary edema and cardiogenic collapse.
  3. Acute Untreated Deep Vein Thrombosis (DVT): Risk of dislodging a clot, causing fatal pulmonary embolism.
  4. Active, Severe Untreated Cellulitis or Phlegmasia Cerulea Dolens.

---

Arterial (Ischemic) Ulcers

Pathophysiology

Arterial ulcers stem from severe peripheral arterial disease (PAD), systemic atherosclerosis, thromboangiitis obliterans (Buerger's disease), or arterial embolization. Luminal narrowing of the iliac, femoropopliteal, or infrapopliteal tibial vessels compromises distal perfusion. When tissue perfusion falls below the basal metabolic requirements of resting cutaneous microcirculation, ischemic cellular death occurs.

Clinical Presentation & Hallmarks

• Anatomical Distribution: Located at the most distal, poorly perfused vascular watershed zones: tips of the toes, interdigital web spaces, phalangeal heads, over the lateral malleolus, or over the anterior pretibial crest. They frequently arise at pressure points subjected to constrictive footwear.
• Wound Appearance: Classically described as "punched-out" with sharp, well-demarcated, clean, smooth wound edges. The wound bed is deep, pale, gray, yellow, or desiccated black necrotic eschar. Granulation tissue is completely absent or severely stunted.
• Exudate: Minimal to completely dry; wound beds lack the perfusion required to generate inflammatory exudate.
• Periwound & Extremity Inspection:
  • Skin is thin, pale, taut, shiny, cool or ice-cold to touch, and completely hairless (loss of hair follicles below the mid-calf).
  • Toenails are dystrophic, thickened, brittle, and slow-growing.
  • Peripheral arterial pulses (dorsalis pedis and posterior tibial) are severely diminished ($1+$) or absent ($0$) on manual palpation and may require continuous-wave Doppler evaluation.
• Pain Profile: Characterized by severe, sharp, aching, burning pain. Patients experience classic intermittent claudication (pain in calves/buttocks triggered by fixed walking distances and relieved by rest), progressing to ischemic rest pain. Rest pain is exacerbated by leg elevation (which eliminates gravity-assisted flow) and is partially relieved by dangling the extremity over the side of the bed in a dependent position.

Physical Diagnostic Tests for Ischemia

1. Dependent Rubor & Elevation Pallor (Buerger's Test):
   • Have the patient lie supine and elevate both lower extremities to $45^\circ\text{ to }60^\circ$ for 60 seconds. In severe arterial disease, the plantar foot turns chalky white or ghost-pale (elevation pallor).
   • Return the legs to a dependent hanging position over the edge of the bed. A delay of $>20\text{ to }30\text{ seconds}$ for capillary color return, followed by the appearance of an intense, deep fiery red or violaceous discoloration (dependent rubor), confirms severe chronic ischemia. This rubor is caused by compensatory, maximal dilatation of the microvascular arterioles that become engorged with deoxygenated blood under gravity.
2. Capillary Refill Time (CRT): Prolonged CRT $>3\text{ to }4\text{ seconds}$ over the hallux or distal pulp indicates microvascular compromise.

---

The Ankle-Brachial Index (ABI) Diagnostic Matrix

The Ankle-Brachial Index is the standard, non-invasive bedside hemodynamic test used to quantify lower-extremity arterial perfusion and screen for peripheral arterial disease.

Performing the Bedside ABI

1. Place the patient supine in a warm environment and allow them to rest quietly for at least $10\text{ minutes}$.
2. Measure the systolic blood pressure in both brachial arteries using a continuous-wave Doppler probe ($5\text{--}8\text{ MHz}$) and an appropriately sized sphygmomanometer cuff. Record the higher of the two brachial systolic pressures as the denominator.
3. Measure the systolic blood pressure in both the dorsalis pedis (DP) and posterior tibial (PT) arteries in each ankle. Record the higher of the two ankle pressures for each respective limb as that limb's numerator.

$\text{ABI}_{\text{Right}} = \frac{\text{Highest Systolic Pressure in Right Ankle (DP or PT)}}{\text{Highest Systolic Pressure of BOTH Brachial Arteries (Right or Left)}}$

ABI Clinical Interpretation Matrix

[!IMPORTANT] The Toe-Brachial Index (TBI) Alternative: Digital toe arteries rarely develop medial calcification, even in advanced diabetes and end-stage renal disease. When the standard ankle cuff yields an $\text{ABI} > 1.30\text{--}1.40$, the clinician measures digital toe pressure using a photoplethysmography (PPG) sensor and a miniature toe cuff. A normal TBI is $\ge 0.70$. A $\text{TBI} < 0.70$ confirms underlying peripheral arterial disease, while a digital toe systolic pressure $< 30\text{ mmHg}$ signifies critical limb ischemia and an inability to heal wounds without revascularization.

---

Diabetic Foot Ulcers (DFU) & Neuropathic Wounds

Diabetic foot ulcers represent the converging end-product of a lethal triad: peripheral neuropathy, biomechanical structural foot deformity, and peripheral arterial disease.

┌────────────────────────────────────────────────────────────────────────┐
│                     THE DIABETIC FOOT ULCER TRIAD                      │
├──────────────────────────┬─────────────────────────────────────────────┤
│ Sensory Neuropathy       │ Loss of Protective Sensation (LOPS);       │
│                          │ repetitive painless micro-trauma.           │
├──────────────────────────┼─────────────────────────────────────────────┤
│ Motor Neuropathy         │ Intrinsic muscle atrophy, hammer/claw toes, │
│                          │ plantar fat pad displacement.               │
├──────────────────────────┼─────────────────────────────────────────────┤
│ Autonomic Neuropathy     │ Anhidrosis, dry cracked skin, AV shunting,  │
│                          │ Charcot neuroarthropathy.                   │
└──────────────────────────┴─────────────────────────────────────────────┘

The Three Neuropathic Facets

1. Sensory Neuropathy: Loss of large- and small-fiber peripheral sensation abolishes the patient's normal physiological protective pain response (Loss of Protective Sensation [LOPS]). Patients walk for hours or days with foreign objects in their shoes (tacks, pebbles, folded insoles) or ill-fitting footwear, creating painless blisters and deep tissue crush injuries that ulcerate without the patient's awareness.
2. Motor Neuropathy: Chronic motor nerve axonopathy leads to progressive atrophy of the lumbrical and interosseous intrinsic foot musculature. The unopposed pull of the larger extrinsic extensor muscles results in severe structural skeletal deformities: hammer toes, claw toes, prominent plantar metatarsal heads, and distal migration of the shock-absorbing submetatarsal fibro-fatty pad. Focal pressure peaks astronomically directly beneath the metatarsal heads during walking.
3. Autonomic Neuropathy: Sympathetic denervation eliminates normal sudomotor and vasomotor function. The foot exhibits anhidrosis (absence of sweating), resulting in dry, inelastic, xerotic skin that rapidly cracks and forms thick hyperkeratotic calluses. Furthermore, loss of vascular tone promotes pathological arteriovenous shunting, creating a paradoxically warm, pink foot with bounding pedal pulses, but severely diminished capillary nutrient perfusion.

Bedside Neuropathy Screening: The Semmes-Weinstein Monofilament Test

The gold standard for identifying Loss of Protective Sensation is the Semmes-Weinstein 5.07 / 10-gram monofilament:

• Technique: Hold the monofilament perpendicular to the patient's skin. Apply pressure until the monofilament bows or buckles into a C-shape for approximately $1.5\text{ seconds}$, then release. Avoid calluses, scars, and open ulcers.
• Anatomical Testing Sites: Systematically test 10 designated plantar sites on each foot: plantar surfaces of the 1st (hallux), 3rd, and 5th toes; plantar surfaces of the 1st, 3rd, and 5th metatarsal heads; medial and lateral midfoot; plantar calcaneus (heel); and dorsal first web space.
• Diagnostic Threshold: Inability to perceive the 10-gram buckling sensation at even a single site (>= 1) confirms Loss of Protective Sensation (LOPS) and classifies the patient as high-risk for future ulceration and amputation.

Charcot Neuroarthropathy (Charcot Foot)

Charcot foot is a severe, progressive, destructive neurovascular complication affecting the bones, joints, and soft tissues of the foot and ankle:

• Pathophysiology: Autonomic-induced hyperperfusion triggers intense localized osteoclast activation and bone demineralization. Repetitive microtrauma on an insensate foot leads to trabecular microfractures, joint capsular tears, ligamentous rupture, subluxation, and complete joint architectural collapse.
• Acute Presentation (Critical CP Diagnostic Trap): The acute phase manifests as a unilaterally hot, profoundly swollen, erythematous, edematous foot and ankle in a patient with dense neuropathy. Pedal pulses are typically bounding. The foot temperature is typically $>2^\circ\text{C}$ ($3.6^\circ\text{F}$) warmer than the contralateral limb on infrared dermal thermometry. Because sensation is impaired, the patient may report only mild aching or no pain at all.
• Misdiagnosis Danger: Acute Charcot foot is frequently misdiagnosed as acute cellulitis, gout, or deep vein thrombosis. If the patient is prescribed oral antibiotics and permitted to continue ambulating, the tarsal and metatarsal bones fracture and collapse, producing the classic permanent "rocker-bottom foot" deformity with an outward convex midfoot plantar prominence that inevitably ulcerates.
• Field Management: Suspected acute Charcot foot is a medical emergency requiring immediate total non-weight-bearing immobilization (crutches, wheelchair, splint) and urgent podiatric/orthopedic referral.

The Probe-to-Bone (PTB) Test for Osteomyelitis

In any open diabetic foot ulcer, the Community Paramedic must assess for deep bone infection:

• Technique: Using sterile technique, gently insert a sterile, blunt-ended metallic probe into the deepest portion of the wound bed until firm resistance is encountered.
• Positive Test: If the probe contacts a hard, gritty, rocky, solid surface with no intervening soft tissue cushion, the Probe-to-Bone test is positive.
• Clinical Significance: In high-risk populations, a positive PTB test has an $85%\text{ to }90%$ positive predictive value for underlying osteomyelitis. A positive test mandates plain foot radiography, consideration of advanced imaging (MRI or nuclear medicine scan), blood cultures, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and prompt surgical/infectious disease consultation.

DFU Offloading Principles

Wounds cannot heal if repetitive mechanical shear and vertical peak pressures continue to re-injure granulating tissue with every step:

• Total Contact Casting (TCC): The recognized gold standard for healing neuropathic plantar ulcers. A custom, minimally padded, rigid fiberglass cast conforms exactly to the plantar contours, distributing weight across the entire leg and offloading up to $85%$ of peak pressure from the forefoot while enforcing compliance.
• Removable Cast Walkers (RCWs): Prefabricated pneumatic walker boots. To prevent non-compliance (patients removing boots inside their homes), clinicians often convert RCWs into an "instant total contact cast" (iTCC) by wrapping cohesive bandages or zip-ties around the outer shell.
• Therapeutic Diabetic Footwear: Extra-depth shoes with custom heat-molded plastazote insoles and rigid rocker soles designed strictly for secondary prevention after ulcer closure, not for healing active plantar wounds.